Guideline Med Alerts & FDA Approvals – July 2024
A list of all the FDA approved medications in July 2024.
Guideline Central Blog
Guidelines
Clinical Guideline Alerts – July 2024
A list of clinical practice guidelines and guideline summaries that were updated or published in July 2024.
The World Health Organization (WHO) – Guidelines International Series
In the latest installment of our Guidelines International Series, we will be delving into the latest guidelines from the World Health Organization (WHO). Established in 1948, WHO is a specialized agency of the United Nations (UN) that facilitates collaboration between nations, partners, and individuals to advance global health, ensure global security, and support marginalized populations. […]
Soft Tissue Sarcoma – Guidelines+ Trials Rundown
Today we’re going to look at the ongoing studies and clinical trials specific to soft tissue sarcomas in adults. The below list was curated by assessing the ongoing Phase 3 trials for soft tissue sarcomas, specific to adults, and based in the United States. The dates provided are estimates, and subject to change. The list […]
Substance Use & Mental Health – Guidelines Rundown
We understand the critical role you play in supporting patients and communities impacted by substance use and mental health disorders. To aid your efforts, we’ve compiled a comprehensive list of essential guidelines from leading medical societies published in recent years. These guidelines are designed to enhance your practice and improve patient outcomes. Your dedication to […]
Advances in Hemochromatosis – Guidelines+ Trials Rundown
Today, we will explore the latest research and clinical trials focused on the management of hemochromatosis. The following list has been carefully curated by evaluating ongoing trials related to hemochromatosis in the United States. Please note that the dates provided are approximate and may be subject to change. The list primarily includes studies with results […]
Guideline Med Alerts & FDA Approvals – June 2024
A list of all the FDA approved medications in June 2024.
Clinical Guideline Alerts – June 2024
A list of clinical practice guidelines and guideline summaries that were updated or published in June 2024.
Advances in Juvenile Arthritis – Guidelines+ Trials Rundown
We’re going to take a look at the ongoing studies and clinical trials specific to juvenile arthritis. The below list was curated by assessing the ongoing Phase 3 trials for juvenile arthritis that are based in the United States. The dates provided are estimates, and subject to change. The list is primarily studies that have […]
Gout in Adults – Guidelines+ Trials Rundown
Today we’re going to look at the ongoing studies and clinical trials specific to gout in adults. The below list was curated by assessing the ongoing Phase 3 trials for gout, specific for adults, and based in the United States. The dates provided are estimates, and subject to change. The list is primarily studies that […]
Celiac Disease in Adults – Guidelines+ Trials Rundown
Today we’re going to look at the ongoing studies and clinical trials specific to celiac disease in adults. The following list has been curated by evaluating the current Phase 2 and 3 clinical trials for celiac disease in adults conducted in the United States. Please note that the dates provided are approximate and may be […]
Migraine Prevention in Adults – Guidelines+ Trials Rundown
Today we’re going to cover the second article in a two part series that takes a look at the ongoing studies and clinical trials specific to management of migraine in adults, including acute migraine treatment and migraine prevention (both chronic migraine prevention and episodic migraine prevention). The focus of Part 1 was Acute Migraine Treatment […]
Guideline Med Alerts & FDA Approvals – May 2024
Breyanzi (Bristol Myers Squibb)Expanded Indication Retevmo (Eli Lilly) Expanded Indication Onyda XR (Tris Pharma) Bkemv (Amgen)Biosimilar to Soliris Opuviz (Biogen) Biosimilar to Eylea Yesafili (Biocon Biologics) Biosimilar to Eylea Imdelltra (Amgen) Clinolipid (Baxter) Expanded Indication ColoSense (Geneoscopy) New Formulation Myhibbin (Azurity Pharmaceuticals) New Formulation Cyltezo (Boehringer Ingelheim) New Formulation Sign up for alerts and stay informed on […]
Clinical Guideline Alerts – May 2024
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2024 Guideline Central, All rights reserved.
Comparing Atopic Dermatitis Guidelines – Guidelines Side-By-Side Series
For this installment of our Guidelines Side-By-Side Series, we’re going to take a look at the current guidelines for atopic dermatitis (AD), commonly referred to as eczema. It is a chronic inflammatory skin condition, identified by dry, itchy skin that may release clear fluid when scratched. The National Institutes of Health (NIH) estimates that this […]
Schizophrenia in Adults – Guidelines+ Trials Rundown
Today we’re going to look at the ongoing studies and clinical trials specific to management of schizophrenia in adults, including in acutely psychotic people with schizophrenia and relapse prevention. The below list was curated by assessing the ongoing Phase 3 trials for migraine treatments, specific for adults, and based in the United States. The dates […]
Comparing Five Current Hepatocellular Carcinoma Clinical Guidelines – Guidelines Side-By-Side Series
For the next installment of our Guidelines Side-By-Side series, we’re going to take a look at the current guidelines for liver cancer. This article will examine how the recommendations in each guideline agree, contradict, or otherwise differ. Our topic for today will be systemic treatment for metastatic hepatocellular carcinoma. The focus will be limited to […]
New Clinical Practice Guidelines & FDA Approvals – April 2024
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Approvals – March 2024
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – February 2024
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – January 2024
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – December 2023
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – November 2023
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – October 2023
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
New Clinical Practice Guidelines & FDA Drug Approvals – September 2023
Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia Author:American College of Obstetricians and Gynecologists (ACOG) Published:September 1, 2023 Outpatient Treatment of Confirmed COVID-19 Author:American College of Physicians (ACP) Published:September 19, 2023 Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis with Secondary Arthritis […]